Bouma, Femke
Nyberg, Fredrik
Olin, Anna-Carin
Carlsen, Hanne Krage
Funding for this research was provided by:
Swedish Research Council for Worklife and Social research (2001-0263, 2001-0263, 2001-0263)
Swedish Heart and Lung Foundation (20050561, 20050561, 20050561)
AstraZeneca
The Swedish Research Council FORMAS
The Swedish Society for Medical Research
Swedish Environmental Protection Agency
University of Gothenburg
Article History
Received: 19 September 2022
Accepted: 2 June 2023
First Online: 29 June 2023
Declarations
:
: The study protocol for ADONIX was approved by the Västra Götaland region ethical review board.
: Does not apply.
: Anna-Carin Olin is one of the inventors of the PExA method and shareholder and boardmember of PExA AB. The authors declare no competing interests relevant to this manuscript.The authors declare no perceived or real competing financial interests relevant to this manuscript.